// App-Quantinova.ai

: Smoking Confers Poor Survival in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with the Combination of Intensive Therapy with Tyrosine Kinase Inhibitor (TKI)

Researchers

Presenter

  • Elias J. Jabbour

Principal Investigators

  • Koji Sasaki

  • Farhad Ravandi

  • Nicholas J Short

  • Guillermo Garcia-Manero

  • Naval G. Daver

  • Tapan M. Kadia

  • Marina Y. Konopleva

  • Nitin Jain

  • Ghayas C. Issa

  • Zeev E. Estrov

  • Rebecca E. Garris

  • Maria Khouri

  • Patrice Nasnas

  • Naveen Pemmaraju

  • Jorge E. Cortes

  • Susan M. O'Brien

  • Hagop M. Kantarjian

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • UC Irvine Health, Chao Family Comprehensive Cancer Center, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Philadelphia chromosome–positive (Ph+) ALL

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved